We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...

Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...

The results of MASS COMM support the safety of performing percutaneous coronary intervention at centres without on-site cardiothoracic surgery services. To translate these findings into clinical ...

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous ...

SAN DIEGO, CA — Routine thrombectomy with PCI for acute ST-elevation MI (STEMI) does not confer an advantage in CV death, recurrent MI, shock, or severe heart failure over 6 months compared with ...

(UPDATED) A group of leaders in the field of high-risk coronary interventions and their past or current fellows have provided recommendations around what it would take for operators to attain ...

Among centers performing a large number of PCI procedures, the volume of inpatient coronary interventions was not associated with short-term outcomes after either TAVR or transcatheter mitral valve ...

Please provide your email address to receive an email when new articles are posted on . Registry data show transradial access was used for most patients who underwent complex, high-risk PCI.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Regulators are ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a control group consisting of drug-eluting stent (DES) and balloon angioplasty (BA ...